Glomerulonephritis: Current Diagnosis, Treatment and Future Options
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 56
Special Issue Editors
2. Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), 46020 Valencia, Spain
3. Department of Medicine, University of Valencia, 46010 Valencia, Spain
Interests: glomerulonephritis; kidney transplant; nephrology; medicine
Interests: autoimmune diseases with kidney involvement; glomerulonephritis; acute interstitial nephritis; renal involvement in hematological and oncological diseases
Special Issue Information
Dear Colleagues,
Glomerulonephritis is a complex and challenging condition affecting the kidneys, being the cause of ESRD in up to 30% of patients reaching RRT and causing an enormous impact on patients and a burden for the health system.
This Special Issue aims to explore the significant advancements in the diagnosis and management of distinct glomerulonephritis made in recent years.
The topics of interest for publication include, but are not limited to, the latest diagnostic techniques used to identify glomerulonephritis. Additionally, we are interested in hearing about the various treatment options available for patients with glomerulonephritis. Furthermore, we are excited to learn about any promising future treatments or research developments in the field of glomerulonephritis. This could include novel drug therapies, emerging technologies, or potential genetic factors influencing the disease.
For this Special Issue, original research articles and reviews are welcome.
Your contribution to this Special Issue will not only educate our readers but also help advance our understanding of glomerulonephritis and improve patient outcomes. We look forward to receiving your contributions on this important subject.
Dr. Ana I. Ávila
Dr. Montserrat M. Díaz-Encarnación
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glomerulonephritis
- diagnosis
- management
- drug therapies
- treatment
